Determining the predictive value of a pre-operative negative PSMA PET/CT in candidates for radical prostatectomy and extended pelvic lymph node dissection

Determining the predictive value of a pre-operative negative PSMA PET/CT in candidates for radical prostatectomy and extended pelvic lymph node dissection

Bibliographic Details
Main Authors:	D. Meijer, H. De Barros, Y.J.L. Bodar, P.J. Van Leeuwen, B.H.E. Jansen, T.M. Van Der Sluis, H.G. Van Der Poel, J.A. Nieuwenhuijzen, D.E. Oprea-Lager, A.N. Vis
Format:	Article
Language:	English
Published:	Elsevier 2020-11-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168320361620

Similar Items

Biochemical persistence of prostate-specific antigen after robot-assisted laparoscopic radical prostatectomy: Tumor localizations using PSMA PET/CT imaging
by: D. Meijer, et al.
Published: (2020-11-01)

Detection of intraprostatic tumor localisation with 18-Fluorine Prostate-Specific Membrane Antigen (PSMA) PET/CT compared to radical prostatectomy specimens: Is PSMA-targeted biopsy feasible? the DeTeCT trial
by: Y.J.L. Bodar, et al.
Published: (2020-07-01)

Determining the diagnostic value of PSMA-PET/CT imaging in patients with persistent high prostate specific antigen levels and negative prostate biopsies. The SESAME-study
by: Y.J.L. Bodar, et al.
Published: (2020-11-01)

Prospective evaluation of pelvic lymph node staging with 18fluorine prostate-specific membrane antigen PET/CT prior to extended lymph node dissection in primary prostate cancer – the SALT trial
by: B.H.E. Jansen, et al.
Published: (2020-07-01)

Standardized uptake values are adequate measures of [18F]DCFPyL PSMA PET/CT uptake in patients with low prostate cancer disease burden
by: Y.J.L. Bodar, et al.
Published: (2020-11-01)

Higher Preoperative Maximum Standardised Uptake Values (SUV<sub>max</sub>) Are Associated with Higher Biochemical Recurrence Rates after Robot-Assisted Radical Prostatectomy for [<sup>68</sup>Ga]Ga-PSMA-11 and [<sup>18</sup>F]DCFPyL Positron Emission Tomography/Computed Tomography
by: Katelijne C. C. de Bie, et al.
Published: (2023-07-01)

Pharmacological Optimization of PSMA-Based Radioligand Therapy
by: Suzanne van der Gaag, et al.
Published: (2022-11-01)

External Validation of Two Nomograms Developed for 68Ga-PSMA-11 Applied to the Prostate-specific Membrane Antigen Tracer 18F-DCFPyl: Is Prediction of the Optimal Timing of Salvage Therapy Feasible?
by: Henk B. Luiting, et al.
Published: (2021-06-01)

Comment on Rosenzweig et al. Very Low Prostate PET/CT PSMA Uptake May Be Misleading in Staging Radical Prostatectomy Candidates. <i>J. Pers. Med.</i> 2022, <i>12</i>, 410
by: Hans Veerman, et al.
Published: (2022-05-01)

Identifying Patients in Whom the Follow-Up Scheme after Robot-Assisted Radical Prostatectomy Could Be Optimized in the First Year after Surgery: Reducing Healthcare Burden
by: Hans Veerman, et al.
Published: (2023-02-01)

Targeting PSMA Revolutionizes the Role of Nuclear Medicine in Diagnosis and Treatment of Prostate Cancer
by: Wietske I. Luining, et al.
Published: (2022-02-01)

Development and Internal Validation of a Novel Nomogram Predicting the Outcome of Salvage Radiation Therapy for Biochemical Recurrence after Radical Prostatectomy in Patients without Metastases on Restaging Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography
by: Dennie Meijer, et al.
Published: (2024-03-01)

First in-men evaluation of OTL78, a near-infrared fluorescent prostate-specific membrane antigen-targeting probe, in prostate cancer patients undergoing radical prostatectomy
by: H.G. Van Der Poel, et al.
Published: (2023-02-01)

Clinical verification of 18F-DCFPyL PET-detected lesions in patients with biochemically recurrent prostate cancer.
by: Dennie Meijer, et al.
Published: (2020-01-01)

Automated pelvic MRI measurements associated with urinary incontinence for prostate cancer patients undergoing radical prostatectomy
by: Ingeborg van den Berg, et al.
Published: (2024-01-01)

Selection of patients for nerve sparing surgery in robot‐assisted radical prostatectomy
by: André N. Vis, et al.
Published: (2022-01-01)

The Impact of Omitting Contralateral Systematic Biopsy on the Surgical Planning of Patients with a Unilateral Suspicious Lesion on Magnetic Resonance Imaging Undergoing Robot-assisted Radical Prostatectomy for Prostate Cancer
by: Daniël L. van den Kroonenberg, et al.
Published: (2024-05-01)

Surgisense - adding sense to vision-guided surgery: Fingertip molecular sensing
by: H.G. Van Der Poel, et al.
Published: (2023-11-01)

Pre-operative MRI in guiding surgical treatment of apical tumors: Why radical resection fails
by: A.N. Veerman, et al.
Published: (2020-11-01)

Predictors of urinary incontinence after radical prostatectomy based on high-volume center cohort and a systematic review
by: N. Grivas, et al.
Published: (2023-02-01)

Effects of furosemide and tracer selection on urinary activity and peri-bladder artefacts in PSMA PET/CT: a single-centre retrospective study
by: Maarten L. Donswijk, et al.
Published: (2022-07-01)

Identifying the relationship between postoperative urinary continence and residual urethra stump measurements in robot assisted radical prostatectomy patients
by: A.J.W. Beulens, et al.
Published: (2020-11-01)

Clinical impact of PSMA PET/CT in primary prostate cancer compared to conventional nodal and distant staging: a retrospective single center study
by: Maarten L. Donswijk, et al.
Published: (2020-08-01)

Update to a randomized controlled trial of lutetium-177-PSMA in Oligo-metastatic hormone-sensitive prostate cancer: the BULLSEYE trial
by: Bastiaan M. Privé, et al.
Published: (2021-11-01)

Lutetium-177-PSMA-I&T as metastases directed therapy in oligometastatic hormone sensitive prostate cancer, a randomized controlled trial
by: Bastiaan M. Privé, et al.
Published: (2020-09-01)

Cost-utility analysis on robot-assisted and laparoscopic prostatectomy based on long-term functional outcomes
by: Melanie A. Lindenberg, et al.
Published: (2022-05-01)

Necessity of Pelvic Lymph Node Irradiation in Patients with Recurrent Prostate Cancer after Radical Prostatectomy in the PSMA PET/CT Era: A Narrative Review
by: Naeim Nabian, et al.
Published: (2022-12-01)

The EAU biochemical recurrence risk stratification after radical prostatectomy
by: T. Van Den Broeck, et al.
Published: (2020-07-01)

Can PSMA PET/CT help in dose-tailoring in post-prostatectomy radiotherapy?
by: Ambroise Champion, et al.
Published: (2023-09-01)

PSMA PET/CT to guide salvage treatment post prostatectomy: The IMPPORT trial
by: S. Koschel, et al.
Published: (2020-07-01)

Does Centralization of Radical Prostatectomy Reduce the Incidence of Postoperative Urinary Incontinence?
by: Maike H.J. Schepens, et al.
Published: (2023-12-01)

A survey on postoperative results analysis and surgical video review of robot-assisted radical prostatectomy: How do they do it?
by: A.J.W. Beulens, et al.
Published: (2020-11-01)

Impact of lymph node burden on survival of high-risk prostate cancer patients following radical prostatectomy and pelvic lymph node dissection
by: Lisa Moris, et al.
Published: (2016-12-01)

Artificial Intelligence‐Supported Video Analysis as a Means to Assess the Impact of DROP‐IN Image Guidance on Robotic Surgeons: Radioguided Sentinel Lymph Node versus PSMA‐Targeted Prostate Cancer Surgery
by: Samaneh Azargoshasb, et al.
Published: (2023-10-01)

Management of pelvic lymphoceles following robot-assisted laparoscopic radical prostatectomy
by: Omer A Raheem, et al.
Published: (2012-01-01)

Tolerability of concurrent external beam radiotherapy and [177Lu]Lu-PSMA-617 for node-positive prostate cancer in treatment naïve patients, phase I study (PROQURE-I trial)
by: Esmée C. A. van der Sar, et al.
Published: (2023-03-01)

Prediction of pathological response following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: the PRE-PREVENCYS trial
by: F. J. Hinsenveld, et al.
Published: (2021-10-01)

Advances in <sup>177</sup>Lu-PSMA and <sup>225</sup>Ac-PSMA Radionuclide Therapy for Metastatic Castration-Resistant Prostate Cancer
by: Sui Wai Ling, et al.
Published: (2022-10-01)

Pelvic Rehabilitation for Urinary Incontinence after Radical Prostatectomy
by: Tvrtko Hudolin, et al.
Published: (2022-01-01)

Impact of Pelvic Anatomical Changes Caused by Radical Prostatectomy
by: Yoshifumi Kadono, et al.
Published: (2022-06-01)